Multiple domains contribute to the distinct inactivation properties of human heart and skeletal muscle Na+ channels

Circulation Research

Volumn 78, Issue 2, 1996, Pages 244-252

  Makita, Naomasa ^a   Bennett Jr , Paul B ^a   George Jr , Alfred L ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

electrophysiology; ion channel gating; Na+ channel

Indexed keywords

COMPLEMENTARY DNA; MUSCLE PROTEIN; PROTEIN SUBUNIT; SODIUM ION;

ARTICLE; CHIMERA; HEART ELECTROPHYSIOLOGY; HEART MUSCLE EXCITABILITY; HEART MUSCLE FIBER MEMBRANE; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DOMAIN; SKELETAL MUSCLE; SODIUM TRANSPORT; VOLTAGE CLAMP;

EID: 0030052822     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.78.2.244     Document Type: Article

References (37)

1. Catterall WA. Cellular and molecular biology of voltage-gated sodium channels. Physiol Rev. 1992;72:S15-S48.
2. Hondeghem LM, Katzung BG. Anti-arrhythmic agents: the modulated receptor mechanism of action of sodium channel blocking drugs. Annu Rev Pharmacol Toxicol. 1987;24:387-423.
3. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80: 805-811.
4. Bennett PB, Yazawa K, Makita N, George AL Jr. Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995;376: 683-685.
5. Stühmer W, Conti F, Suzuki H, Wang X, Noda M, Yahagi N, Kubo H, Numa S. Structural parts involved in activation and inactivation of the sodium channel. Nature. 1989;339:597-603.
6. Vassilev P, Scheuer T, Catterall WA. Inhibition of inactivation of single sodium channels by a site-directed antibody. Proc Natl Acad Sci U S A. 1989;86:8147-8151.
7. +-channel inactivation: charge neutralizations and deletions in the III-IV linker. Proc Natl Acad Sci U S A. 1992;89:10905-10909.
8. +-channel inactivation. Proc Natl Acad Sci U S A. 1992;89: 10910-10914.
9. Trimmer JS, Cooperman SS, Tomiko SA, Zhou J, Crean SM, Boyle MB, Kallen RG, Sheng Z, Barchi RL, Sigworth FJ, Goodman RH, Agnew WS, Mandel G. Primary structure and functional expression of a mammalian skeletal muscle sodium channel. Neuron. 1989;3: 33-49.
10. + channel isoform. FEBS Lett. 1990;275: 195-200.
11. + channel. Mol Pharmacol. 1991;39:604-608.
12. + current conducted by the rat skeletal muscle α subunit by coexpression with a human brain β subunit. Pflugers Arch. 1993;423: 155-157.
13. 1 subunit modifies activation and inactivation gating of multiple sodium channel α subunits. J Biol Chem. 1994;269:17649-17655.
14. Bennett PB Jr, Makita N, George AL Jr. A molecular basis for gating mode transitions in human skeletal muscle sodium channels. FEBS Lett. 1993;326:21-24.
15. 1 subunit mRNA expressed in adult human skeletal muscle, heart, and brain is encoded by a single gene. J Biol Chem. 1994;269:7571-7578.
16. George AL, Komisarof J, Kallen RG, Barchi RL. Primary structure of the adult human skeletal muscle voltage-dependent sodium channel. Ann Neurol. 1992;31:131-137.
17. Chahine M, Bennett PB, George AL Jr, Horn R. Functional expression and properties of the human skeletal muscle sodium channel. Pflugers Arch. 1994;427:136-142.
18. Gellens ME, George AL, Chen L, Chahine M, Horn R, Barchi RL, Kallen RG. Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc Natl Acad Sci U S A. 1992;89:554-558.
19. Chahine M, George AL Jr, Zhou M, Ji S, Sun W, Barchi RL, Horn R. Sodium channel mutations in paramyotonia congenita uncouple inactivation from activation. Neuron. 1994;12:281-294.
20. Higuchi R. Using PCR to engineer DNA. In: Erlich HA, ed. PCR Technology. New York, NY: Stockton Press; 1989:61-70.
21. Krieg PA, Melton DA. In vitro RNA synthesis with SP6 RNA polymerase. Methods Enzymol. 1987;155:397-415.
22. + channel inactivation gating. Circ Res. 1994;75:114-122.
23. Cannon SC, Strittmatter SM. Functional expression of sodium channel mutations identified in families with periodic paralysis. Neuron. 1993;10:317-326.
24. + channel mutation causing hyperkalemic periodic paralysis. Neuron. 1993;10: 667-678.
25. Yang N, Ji S, Zhou M, Ptacek LJ, Barchi RL, Horn R, George AL Jr. Sodium channel mutations in paramyotonia congenita exhibit similar biophysical phenotypes in vitro. Proc Natl Acad Sci U S A. 1994;91:12785-12789.
26. Mitrovic N, George AL Jr, Heine R, Wagner S, Pika U, Hartlaub U, Zhou M, Lerche H, Fahlke CH, Lehmann-Horn F. Potassium-aggravated myotonia: the V1589M mutation destabilizes the inactivated state of the muscle sodium channel. J Physiol (Lond). 1994; 478:395-402.
27. + channel. Nature. 1991;353:86-90.
28. Zhang J-F, Ellinor PT, Aldrich RW, Tsien RW. Molecular determinants of voltage-dependent inactivation in calcium channels. Nature. 1994;372:97-100.
29. Chen L-Q, Chahine M, Kallen RG, Barchi RL, Horn R. Chimeric study of sodium channels from rat skeletal and cardiac muscle. FEBS Lett. 1992;309:253-257.
30. Zhang JF, Ellinor PT, Tsien RW, Aldrich RW. Molecular determinants of sodium channel inactivation include residues near segment IS6. Biophys J. 1995;68:A361. Abstract.
31. Roberts RH, Barchi RL. The voltage-sensitive sodium channel from rabbit skeletal muscle: chemical characterization of subunits. J Biol Chem. 1987;262:2298-2303.
32. 1 subunits of sodium channels: studies with subunit-specific antibodies. J Biol Chem. 1990;265: 12393-12399.
33. Cohen SA, Levitt LK. Partial characterization of the rH1 sodium channel protein from rat heart using subtype-specific antibodies. Circ Res. 1993;73:735-742.
34. 1 subunit of the rat brain sodium channel. Science. 1992;256:839-842.
35. Thomsen WJ, Catterall WA. Localization of the receptor site for α-scorpion toxins by antibody mapping: implications for sodium channel topology. Proc Natl Acad Sci U S A. 1989;86:10161-10165.
36. Garritsen A, Simonds WF. Multiple domains of G protein β confer subunit specificity in β-gamma interaction. J Biol Chem. 1994;269: 24418-24423.
37. Marullo S, Emorine LJ, Strosberg AD, Delavier-Klutchko C. Selective binding of ligands to β1, β2 or chimeric β1/β2-adrenergic receptors involves multiple subsites. EMBO J. 1990;9:1471-1476.